Registrations open for SOSV’s First Sustainable Industry Tech Matchup. Learn More.

Dandelion Bio

Lipid nanoparticle discovery and design with generative AI


Payam Khoshkenar

CEO & Co-Founder

Hadi Nayebi


Morteza Rasoulian


Company details

More info at the IndieBio website

Similar to bubble wraps in protecting fragile items, Lipid Nanoparticles (LNPs) are the protective shield in delivery of delicate mRNA molecules. Thanks to the advancements in genomic medicine, it takes less than a week to design and manufacture any mRNA molecule. However, it took more than 10 years to build the LNPs that we received in mRNA covid vaccines. The huge chemical space of lipids is the pain point in the discovery of organ targeting LNPs. Dandelion enables a generative AI to design organs targeting LNPs from first principles. They’re actively partnering with leaders in the industry.

Get In Touch with Dandelion Bio

Please tell us a little bit about yourself and why you'd like to get connected. Dandelion Bio + SOSV will follow up with you via email.


No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.